Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents

Abdallah Hamzé (1) , Mouad Alami (2) , Olivier Provot (2)

1 IBMM - Institut des Biomolécules Max Mousseron [Pôle Chimie Balard]
2 BioCIS - Biomolécules : Conception, Isolement, Synthèse

Combretastatin A-4 (CA-4) is a natural anti-cancer agent isolated in 1989 from the African willow tree, Combretum caffrum. Due to its chemical simplicity, this (Z)-stilbene has been the subject of many structural modifications mainly to improve its chemical and metabolic stability. Beside a large number of synthetic analogues, isoCombretastatin A-4 (isoCA-4), has proved to be a solution of choice since this non-natural isomer of CA-4 is stable, easier to synthesize and has equivalent antitumor properties as CA-4. In this review, we will present the structure-activity relationships (SARs) around isoCA-4 since its discovery in 2007. In a first part, we will describe some alternatives to replace the phenol Bring of isoCA-4, then we will focus on the variations made on the 1,1-ethylene double bond and then, we will evocate very recent exiting results concerning the possible replacements of the 3,4,5-trimethoxyphenyl A-ring of isoCA-4 by suitable heterocycles.

Mots clés: Combretastatin A-4; isoCombretastatin A-4; Heterocycles; Cytotoxicity; Tubulin; Cancer

Domaines: Chimie; Génie chimique; Chimie thérapeutique

Abdallah Hamzé, Mouad Alami, Olivier Provot. Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents. European Journal of Medicinal Chemistry, 2020, 190, pp.112110. ⟨10.1016/j.ejmech.2020.112110⟩. ⟨hal-02910294⟩